Project Grant F32DA060664

Award Date 9/15/24
Completion Date 3/31/26
Dollars Obligated $211K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $210,776 to the Regents of the University of Minnesota to conduct research on input-specific synaptic plasticity in the nucleus accumbens evoked by inhibition of angiotensin-converting enzyme (ACE).

The key objectives of this 1.5-year project are to determine which specific excitatory and inhibitory presynaptic inputs to medium spiny neurons in the nucleus accumbens express ACE inhibitor-induced long-term depression, in order to reveal the circuit-specific synaptic plasticity mechanisms that could inform the development of new treatments for substance use disorders. The research will leverage techniques such as optogenetics and whole-cell patch-clamp electrophysiology to elucidate the role of ACE inhibition and opioid receptor signaling in modulating specific excitatory and inhibitory inputs to these reward-related neurons. This work builds on prior studies suggesting ACE inhibition as a potential therapeutic target for opioid use disorder.

Generated 2/25/25, 5:32 AM